Printer Friendly

Browse Phosphodiesterases topic


1-23 out of 23 article(s)
Title Author Type Date Words
P.arg102ser is a common Pde6[alpha] mutation causing autosomal recessive retinitis pigmentosa in Pakistani families. Khan, Anoshiya Ali; Waryah, Yar Muhammad; Iqbal, Muhammad; Baig, Hafiz Muhammad Azhar; Rafique, Muha Report Mar 31, 2021 2819
The hepatic ectonucleotide pyrophosphatase/phosphodiesterase 1 gene mRNA abundance is reduced by insulin and induced by dexamethasone. Ma, Huiwen; Wang, Ping; Jin, Dan; Jia, Ting; Mao, Hong; Zhang, Jiandi; Zhao, Shi Report Apr 1, 2018 6707
Penile microvascular endothelial function in hypertensive patients: effects of acute type 5 phosphodiesterase inhibition. Verri, V.; Brandao, A.A.; Tibirica, E. Report Mar 1, 2018 5978
Angiotensin-(1-7) Downregulates Diabetes-Induced cGMP Phosphodiesterase Activation in Rat Corpus Cavernosum. Dhaunsi, Gursev S.; Yousif, Mariam; Makki, Batoul; Akhtar, Saghir; Benter, Ibrahim F. Report Jan 1, 2017 4135
Altered protein makes mice smart: genetic tweak points to future treatment for schizophrenia. Sanders, Laura Brief article Sep 19, 2015 285
Phosphodiesterase 4B is essential for lipopolysaccharide-induced CC chemokine ligand 3 production in mouse macrophages. Lai, Ciou-Rong; Lo, Huan-Chu; Chen, Yi-Ling; Yang, Jing-Xing; Ding, Shiau-Li; Hsu, Hsian-He; Conti, Report May 1, 2015 4582
Pharmacokinetics of single oral dose of Pimobendan in Hispaniolan Amazon parrots (Amazona ventralis). Guzman, David Sanchez-Migallon; Beaufrere, Hugues; KuKanich, Butch; Barker, Steven A.; Brandao, Joao Report Jun 1, 2014 4818
Hyperspectral FRET imaging and analysis approaches to determine cAMP compartmentalization in PMVECs. Annamdevula, Naga S.; Britain, Andrea; Rich, Thomas C.; Leavesley, Silas J. Report Apr 1, 2014 1536
Stimulation of neural stem cell proliferation by inhibition of phosphodiesterase 5. Santos, Ana I.; Carreira, Bruno P.; Nobre, Rui J.; Carvalho, Caetana M.; Araujo, Ines M. Report Jan 1, 2014 7800
Benign prostat hiperplazisi ile iliskili alt uriner sistem semptomlannin tedavisinde fosfodiesteraz tip-5 inhibitorlerinin rolu / The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Umul, Mehmet; Serel, Tekin Ahmet Report Dec 1, 2013 4377
Roflumilast cut exacerbation rate in COPD. Jancin, Bruce Dec 1, 2009 496
Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Dallas, Constantin; Gerbi, Alain; Tenca, Guillaume; Juchaux, Franck; Bernard, Freancois-Xavier Report Oct 1, 2008 5092
Sexual activity and cardiovascular risk / Cinsel aktivite ve kardiyovaskuler risk. Boztosun, Bilal; Olcay, Ayhan; Degertekin, Muzaffer Clinical report Dec 1, 2007 3148
Review gives nod to PDE-5 inhibitors in men with diabetes. Wendling, Patrice Feb 1, 2007 618
PDE-5 inhibitors may relieve lower urinary tract symptoms. MacNeil, Jane Salodof May 1, 2006 548
Introduction. Hellstrom, Wayne J.G. Dec 1, 2005 829
Selecting patients appropriate for treatment. Sadovsky, Richard Dec 1, 2005 5707
Rationale for not combining nitrates and PDE5 inhibitors. DeBusk, Robert F.; Kloner, Robert A. Dec 1, 2005 4737
Clinically relevant drug-drug interactions of the PDE5 inhibitors. White, William B. Dec 1, 2005 4970
Evaluating the PDE5 inhibitors: what are the differences? Carson, Culley C.; Rosen, Raymond C. Dec 1, 2005 3440
Vardenafil found superior for improving premature ejaculation. Finn, Robert Nov 1, 2005 330
Revatio. Mechcatie, Elizabeth Jul 15, 2005 338
Primary care task: sexual hx in diabetics: refer men to urologists when needed. Finn, Robert Apr 15, 2004 614

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |